AMNNYSEServices-Help Supply ServicesFiscal year ends December 31
AMN HEALTHCARE SERVICES INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$40.50+0.01 (+0.02%)
Close on Oct 19, 2026
- Market cap
- $1.61B
- P/E (TTM)
- 15.1
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
28.3%−4.7 pts over 5 years
Operating margin
-2.0%−8.3 pts over 5 years
Net margin
-3.5%−6.5 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -8.5% | -19.5% | +2.7% | +6.4% | |
| Gross profit | -15.8% | -23.3% | -0.5% | +5.1% | |
| Free cash flow | -2.4% | -26.0% | +1.3% | +23.1% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 26.6% | 9.1% | -14.2% | |
| Return on assets | 10.2% | 3.3% | -4.2% | |
| Current ratio | 1.64 | 1.26 | 0.94 | |
| Debt to equity | 0.81 | 1.05 | 1.16 | |
| Net debt to EBITDA | 1.41× | 3.20× | 7.00× | |
| Interest coverage | 12.4× | 2.6× | -1.2× | |
| Capex to revenue | 1.2% | 1.6% | 1.3% | |
| Diluted shares | 49M | 48M | 39M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Amn Healthcare Services generated $1.92B from operations and spent $1.35B on capital expenditure, dividends and share buybacks. 26% of that went back into the business.
Generated
$1.92B
Used
$1.35B
Capital expenditure$349.61M26%Dividends$00%Share buybacks$1.00B74%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-3.5%
×Asset turnover1.21×
×Equity multiplier3.34×
=Return on equity, FY2025-14.2%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -3.5% | 1.21× | 3.34× | -14.2% |
| FY2024 | -4.9% | 1.12× | 3.47× | -19.1% |
| FY2023 | 5.6% | 1.30× | 3.10× | 22.5% |
| FY2022 | 8.5% | 1.74× | 2.73× | 40.3% |
| FY2021 | 8.2% | 1.45× | 2.77× | 33.0% |
| FY2020 | 3.0% | 1.12× | 2.75× | 9.1% |
| FY2019 | 5.1% | 1.30× | 2.49× | 16.6% |
| FY2018 | 6.6% | 1.56× | 2.29× | 23.6% |
| FY2017 | 6.7% | 1.63× | 2.41× | 26.2% |
| FY2016 | 5.6% | 1.84× | 2.59× | 26.6% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
4of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$95.70M
- Cash generatingOperating cash flow above zero$269.46M
- Return on assets improvedROA up on the prior year-5.0% → -4.0%
- Earnings backed by cashOperating cash flow above net income$269.46M vs -$95.70M
- Less leverageLong-term debt to assets fell35.0% → 35.4%
- Better liquidityCurrent ratio rose1.09 → 0.94
- No dilutionShare count did not rise38M → 39M
- Gross margin improvedGross margin up on the prior year30.81% → 28.35%
- More efficientAsset turnover rose1.02 → 1.13